Clinical Trial Detail

NCT ID NCT03401385
Title First-in-human Study of DS-1062a for Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Co., Ltd.
Indications

lung non-small cell carcinoma

Therapies

DS-1062a

Age Groups: senior adult

No variant requirements are available.